PROTON PUMP INHIBITION

Evaluating the cost-effectiveness of replacing lansoprazole with vonoprazan for treating erosive oesophagitis
Saeash Jeyarajan, Thejasvin K, Sneha Pimpalnerkar, Emily Zichu Deng, Zain Ahmad, Diya Banerjee, Laure de Preux

BMJ Open Gastroenterology May 2025, 12 (1) e001709; DOI: 10.1136/bmjgast-2024-001709
Proton pump inhibitors and the risk of gastric cancer: a systematic review, evidence synthesis and life course epidemiology perspective
Nele Brusselaers, Habiba (Khodir) Kamal, David Graham, Lars Engstrand

BMJ Open Gastroenterology Apr 2025, 12 (1) e001719; DOI: 10.1136/bmjgast-2024-001719
Economic evaluation of proton pump inhibitors in patients with gastro-oesophageal reflux disease: a systematic review
Seidamir Pasha Tabaeian, Sajad Moeini, Aziz Rezapour, Somayeh Afshari, Aghdas Souresrafil, Mohammad Barzegar

BMJ Open Gastroenterology Dec 2024, 11 (1) e001465; DOI: 10.1136/bmjgast-2024-001465
‘Persistent throat symptoms’ versus ‘laryngopharyngeal reflux’: a cross-sectional study refining the clinical condition
James O'Hara, Holly Fisher, Louise Hayes, Janet Wilson

BMJ Open Gastroenterology Mar 2022, 9 (1) e000850; DOI: 10.1136/bmjgast-2021-000850
Randomised clinical trial: the use of alginates during preinvestigation proton pump inhibitor wash-out and their impact on compliance and symptom burden
Andres Vales, Cathal Coyle, Kate Plehhova, Anthony Hobson, Philip Woodland

BMJ Open Gastroenterology Jan 2023, 10 (1) e001026; DOI: 10.1136/bmjgast-2022-001026
Association between proton pump inhibitors after percutaneous coronary intervention and risk of gastric cancer
Andrew Kei-Yan Ng, Pauline Yeung Ng, April Ip, Ka-Shing Cheung, Chung-Wah Siu

BMJ Open Gastroenterology Aug 2021, 8 (1) e000719; DOI: 10.1136/bmjgast-2021-000719
When does proton pump inhibitor treatment become long term? A scoping review
Peter Fentz Haastrup, Dorte Ejg Jarbøl, Wade Thompson, Jane Møller Hansen, Jens Søndergaard, Sanne Rasmussen

BMJ Open Gastroenterology Feb 2021, 8 (1) e000563; DOI: 10.1136/bmjgast-2020-000563
Development and validation of a lipase nasogastric tube position test
Oliver Anderson, Reuben Carr, Merrilee Harbinson, George Bushra Hanna

BMJ Open Gastroenterology Mar 2016, 3 (1) e000064; DOI: 10.1136/bmjgast-2015-000064
Does long-term use of proton pump inhibitors cause hypomagnesaemia in Japanese outpatients?
Yasuhito Takeda, Hisashi Doyama, Kunihiro Tsuji, Shinya Yamada, Kenichi Takemura

BMJ Open Gastroenterology Jan 2014, 1 (1) e000003; DOI: 10.1136/bmjgast-2014-000003
Effects of proton pump inhibitors and histamine-2 receptor antagonists on response to fidaxomicin or vancomycin in patients with Clostridium difficile-associated diarrhoea
Karl Weiss, Thomas Louie, Mark A Miller, Kathleen Mullane, Derrick W Crook, Sherwood L Gorbach

BMJ Open Gastroenterology Dec 2015, 2 (1) e000028; DOI: 10.1136/bmjgast-2014-000028

Log in using your username and password

Main menu

Log in using your username and password

You are here

PROTON PUMP INHIBITION